Prices displayed include the multi-buy discount => this represents a saving of £1250 / US$1945 / €1500 over buying the volumes separately!

Critical analysis and 5-year forecasts of key point-of-care diagnostic technologies, their prospects and the companies driving change and innovation.
The In Vitro diagnostics market was worth approximately US$43 billion in 2011 and grew approximately 4% compared with 2010. The Point-of-Care (POC) sector represents 35% of the overall market and was valued at US$15.1 billion in 2011.
The products covered in this report include those used by healthcare professionals and self-testers, which accounted for 33% of the POC sector, and consumer POC products which represented 7%. The remaining 60% of sales comes from blood glucose monitoring products.
The POC sector is growing faster than the overall IVD market. During 2011, growth in the POC sector, excluding consumer and glucose testing products, is estimated to have been 7%. Growth was driven by the increasing adoption of all types of POC technologies by both professional and self-testing users, as well as the launch of new products and rising demand in emerging markets.

POC Diagnostics is a sector on the move. Key reasons why it is interesting:

POC diagnostics play a key role in the diagnosis and monitoring of acute and chronic illnesses, the detection of some types of cancer and infectious diseases, and for general blood and urine testing. It can also play a role in preventative medicine, which is intended to help curb the increasing incidence of chronic conditions such as diabetes and cardiovascular disease through early detection and the identification of patients with risk factors.
POC testing offers clear benefits over laboratory testing. As it is conducted near the patient, results are available more quickly, enabling healthcare providers to act swiftly to emergencies such as heart attack and provide a diagnosis while the patient is still in the healthcare facility, speeding treatment and reducing visits to the doctor. For patients, self-testing helps users control effectively their condition which lowers the time and cost of treating complications, and the need for them to regularly see their doctor.
The POC diagnostics market is dominated by well-established and accepted product areas such as infectious disease and pregnancy testing. However, there is major growth potential for the adoption of POC technologies in settings such as hospital emergency, critical care and out-patient departments and areas without access to central labs.

This report collection delivers a complete and insightful analysis
The four volumes of this report collection, originally published Autumn 2012/Spring 2013, make a fascinating and detailed appraisal of this fast-growing sector of the diagnostics industry worldwide. Whatever your interest, the report will provide a one-stop assessment of opportunities and challenges going forward.

A special collection of insightful management reports available as a discounted set:
Vol 1: Cardiology Diagnostics
Vol 2: Hospital-based Diagnostics
Vol 3: Physician-based Diagnostics
Vol 4: Infectious Diseases Diagnostics


Use this extensive 4-volume report to...

Understand the trends which are shaping the sector’s operation
Identify which sectors offer the greatest growth potential over the next 5 years
Highlight the emerging companies in the industry with novel technology
Evaluate the competitive landscape and identify the companies to watch
Know who’s striking strategic and tactical partnerships
Monitor M&A activity and the changing competitive landscape

About the Author

This report has been researched and written by independent medical market analyst Joanne Maddox. For over 13 years she has played a pivotal role in tracking trends in medical device and equipment markets and companies. A former editor of Medical Device Companies Analysis she has also written The Global Advanced Wound Care Market to 2017; Advances in Molecular Imaging 2013; and, Telemonitoring: Challenges and Opportunities.

About the Publisher

For over 30 years Espicom Business Intelligence, a Business Monitor company, has been a leading provider of key medical device and technology data. Its experienced and knowledgeable authors are uniquely placed to produce this high-quality and thoroughly researched management report. Espicom is part of Business Monitor International.

Table Of Contents

Point of Care Diagnostics Market: Products, Players and Outlook

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

2015 Current and Emerging Suppliers Of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

2015 Current and Emerging Suppliers Of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

  • $ 8 500
  • Industry report
  • February 2015
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides analyses of current and emerging suppliers of immunodiagnositc, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood ...

Fetal Monitoring, Diagnostics and Predictive Tests

Fetal Monitoring, Diagnostics and Predictive Tests

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for fetal monitoring, prenatal diagnostics, predictive tests and neonatal monitoring was valued at roughly $8.6 billion in 2013 and about $9.0 billion in 2014. This ...

The US Blood Transfusion Diagnostics Market : Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

The US Blood Transfusion Diagnostics Market : Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

  • $ 6 500
  • Industry report
  • March 2015
  • by Frost & Sullivan

Methodology The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with blood banking product providers. Most consultations ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.